Study of EGF816 in Combination With Selected Targeted Agents in EGFR-mutant NSCLC

EGF816OngoingActive not recruitingPhase 1Open NCT03333343 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…